Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 3/20 | 0.43 |
| ▸ | MME | P08473 | 3/20 | 0.42 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | CPA1 | P15085 | 1/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | ANPEP | P15144 | 1/20 | 0.36 |
| ▸ | ECE1 | P42892 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6954452 | 1.00 | SMN1; SMN2 (0.46) | SMN1; SMN2ALDH1A1KDM4EMAPTFAAH | |
| SCHEMBL30628732 | 1.00 | SMN1; SMN2 (0.46) | SMN1; SMN2ALDH1A1KDM4EMAPTFAAH | |
| SCHEMBL20268790 | 0.92 | MME (0.46) | SMN1; SMN2ALDH1A1KDM4EMAPTFAAH | |
| SCHEMBL20268787 | 0.92 | MME (0.46) | SMN1; SMN2ALDH1A1KDM4EMAPTFAAH | |
| SCHEMBL20268789 | 0.92 | MME (0.46) | SMN1; SMN2ALDH1A1KDM4EMAPTFAAH | |
| SCHEMBL4189346 | 0.78 | ALDH1A1 (0.50) | SMN1; SMN2ALDH1A1KDM4EMAPTFAAH | |
| SCHEMBL4811735 | 0.78 | SMN1; SMN2 (0.47) | SMN1; SMN2ALDH1A1KDM4EMAPTFAAH | |
| SCHEMBL6309640 | 0.78 | SMN1; SMN2 (0.47) | SMN1; SMN2ALDH1A1KDM4EMAPTFAAH | |
| SCHEMBL4811341 | 0.78 | SMN1; SMN2 (0.47) | SMN1; SMN2ALDH1A1KDM4EMAPTFAAH | |
| SCHEMBL10076082 | 0.78 | ALDH1A1 (0.50) | SMN1; SMN2ALDH1A1KDM4EMAPTFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240091315-A1 | XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME | AMUNIX PHARMACEUTICALS, INC. | 2024-03-21 | — | — | US | disclosed |
| US-11725222-B2 | Cleavable nucleotide analogs and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-08-15 | — | — | US | disclosed |
| US-20210322518-A1 | XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME | AMUNIX PHARMACEUTICALS, INC. | 2021-10-21 | — | — | US | disclosed |
| US-10953073-B2 | XTEN conjugate compositions and methods of making same | AMUNIX PHARMACEUTICALS, INC. (US) | 2021-03-23 | — | — | US | disclosed |
| WO-2020243047-A1 | CONTROLLED HEAT DELIVERY COMPOSITIONS | BAMBU VAULT LLC (US) | 2020-12-03 | — | — | WO | disclosed |
| US-20200080122-A1 | Cleavable Nucleotide Analogs and Uses Thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2020-03-12 | — | — | US | disclosed |
| WO-2020037177-A1 | SELF-HEALING, OMNIPHOBIC COATINGS AND RELATED METHODS | UNIVERSITY OF KANSAS (US) | 2020-02-20 | — | — | WO | disclosed |
| US-20190083577-A1 | XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME | AMUNIX PHARMACEUTICALS, INC. | 2019-03-21 | — | — | US | disclosed |
| US-10172953-B2 | XTEN conjugate compositions and methods of making same | AMUNIX OPERATING INC. (US) | 2019-01-08 | — | — | US | disclosed |
| US-10163648-B2 | Method of semiconductor device fabrication having application of material with cross-linkable component | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2018-12-25 | — | — | US | disclosed |
| WO-2016146261-A1 | COMBINATION OF AN IMMUNE CHECKPOINT MODULATOR AND A COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST FOR USE IN MEDICINE | AMAL THERAPEUTICS SA (CH) | 2016-09-22 | — | — | WO | disclosed |
| WO-2016146262-A1 | A NOVEL COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST FOR TREATMENT OF COLORECTAL CANCER | AMAL THERAPEUTICS SA (CH) | 2016-09-22 | — | — | WO | disclosed |
| WO-2016146260-A1 | A NOVEL COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST | AMAL THERAPEUTICS SA (CH) | 2016-09-22 | — | — | WO | disclosed |
| EP-2890703-A1 | SYNTHESIS OF DIVERSE GLYCOSYLPHOSPHATIDYLINOSITOL GLYCANS FROM TOXOPLASMA GONDII AND THEIR APPLICATION AS VACCINES AND DIAGNOSTICS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften (DE) | 2015-07-08 | — | — | EP | disclosed |
| US-20150037359-A1 | XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME | Amunix Operating, Inc. (US) | 2015-02-05 | — | — | US | disclosed |
| WO-2014016317-A1 | SYNTHESIS OF DIVERSE GLYCOSYLPHOSPHATIDYLINOSITOL GLYCANS FROM TOXOPLASMA GONDII AND THEIR APPLICATION AS VACCINES AND DIAGNOSTICS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2014-01-30 | — | — | WO | disclosed |
| US-7595198-B2 | Photocleavable isotope-coded affinity tags | AMBERGEN, INC. (US) | 2009-09-29 | — | — | US | disclosed |
| US-20080032417-A1 | Photocleavable isotope-coded affinity tags | AMBERGEN, INC | 2008-02-07 | — | — | US | disclosed |
| US-7145019-B2 | Photocleavable isotope-coded affinity tags | AMBERGEN, INC. (US) | 2006-12-05 | — | — | US | disclosed |
| US-20050085630-A1 | Photocleavable isotope-coded affinity tags | AMBERGEN INC. | 2005-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150037359-A1 | XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME | XPA, TXLNA, NGLY1 | SMN1; SMN2 1489/4885ALDH1A1 3685/4885KDM4E 2338/4885 |
| US-10172953-B2 | XTEN conjugate compositions and methods of making same | XPA, TXLNA, NGLY1 | SMN1; SMN2 1489/4885ALDH1A1 3685/4885KDM4E 2338/4885 |
| US-20210322518-A1 | XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME | XPA, TXLNA, NGLY1 | SMN1; SMN2 1489/4885ALDH1A1 3685/4885KDM4E 2338/4885 |
| US-10953073-B2 | XTEN conjugate compositions and methods of making same | XPA, TXLNA, NGLY1 | SMN1; SMN2 1489/4885ALDH1A1 3685/4885KDM4E 2338/4885 |
| US-20050085630-A1 | Photocleavable isotope-coded affinity tags | PTMS, DNPEP, ACP1 | SMN1; SMN2 4487/4885ALDH1A1 1588/4885KDM4E 2457/4885 |
| US-20190083577-A1 | XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME | XPA, TXLNA, NGLY1 | SMN1; SMN2 1489/4885ALDH1A1 3685/4885KDM4E 2338/4885 |
| US-20200080122-A1 | Cleavable Nucleotide Analogs and Uses Thereof | TYMP, DUT, NT5C3B | SMN1; SMN2 2082/4885ALDH1A1 3387/4885KDM4E 3510/4885 |
| US-11725222-B2 | Cleavable nucleotide analogs and uses thereof | TYMP, DUT, NT5C3B | SMN1; SMN2 2082/4885ALDH1A1 3387/4885KDM4E 3510/4885 |
| US-20240091315-A1 | XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME | XPA, TXLNA, NGLY1 | SMN1; SMN2 1489/4885ALDH1A1 3685/4885KDM4E 2338/4885 |
| US-20080032417-A1 | Photocleavable isotope-coded affinity tags | PTMS, DNPEP, ACP1 | SMN1; SMN2 4487/4885ALDH1A1 1588/4885KDM4E 2457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.